Karyopharm Therapeutics Inc. (KPTI) total assets

Total assets · fiscal 2025
$108.42M

Karyopharm Therapeutics Inc. (KPTI) had total assets of $108.42M at the end of fiscal 2025 (December 31, 2025). That is 34.1% lower than the $164.42M of fiscal 2024. Figures as of 18 Nov 2026, 07:34 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$108.42M
Change on fiscal 2024
−34.1%
Growth, 5 years
−19.1% a year
Growth, 10 years
−6.6% a year
Highest on record
$358.17Mfiscal 2022
Lowest on record
$1.31Mfiscal 2012
Fiscal years on record
142012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Karyopharm Therapeutics Inc. total assets, in more detail

Over the five fiscal years to 2025 total assets shrank at a compound 19.1% a year; over ten years the rate was −6.6% a year. Across the 14 fiscal years on record (2012–2025), the highest was $358.17M in fiscal 2022 and the lowest $1.31M in fiscal 2012.

History · 14 fiscal years

Total assets by fiscal year

Karyopharm Therapeutics Inc. total assets, year by year

Karyopharm Therapeutics Inc. (KPTI) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$108.42M 34.1% down
2024$164.42M 31.6% down
2023$240.44M 32.9% down
2022$358.17M 17.3% up
2021$305.31M 2.5% down
2020$313.05M 6.1% up
2019$294.96M 13.5% down
2018$341.19M 89.2% up
2017$180.29M 0.1% down
2016$180.39M 16.3% down
2015$215.44M 2.2% down
2014$220.34M 39.3% up
2013$158.23M 11,969.1% up
2012$1.31M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

More on KPTI

Karyopharm Therapeutics Inc., figure by figure

Karyopharm Therapeutics Inc. (KPTI) overview: price, valuation and scorecard

Karyopharm Therapeutics Inc. total assets: questions and answers

How large are Karyopharm Therapeutics Inc.'s total assets?

Karyopharm Therapeutics Inc. (KPTI) had total assets of $108.42M at the end of fiscal 2025 (December 31, 2025). That is 34.1% lower than the $164.42M of fiscal 2024.

What is the growth rate of Karyopharm Therapeutics Inc.'s total assets?

Over the five fiscal years to 2025 total assets shrank at a compound 19.1% a year; over ten years the rate was −6.6% a year.

What are the highest and lowest total assets figures on record for Karyopharm Therapeutics Inc.?

Across the 14 fiscal years on record (2012–2025), the highest was $358.17M in fiscal 2022 and the lowest $1.31M in fiscal 2012.

How is Karyopharm Therapeutics Inc.'s total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Karyopharm Therapeutics Inc. (KPTI) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/KPTI/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.